(Press-News.org) NEW YORK, MARCH 14, 2012 – Researchers have identified a set of genetic abnormalities in patients with acute myelogenous leukemia (AML) that doctors can use to more accurately predict patients' prognoses and select treatments that are most likely to benefit them. The study, led by investigators at Memorial Sloan-Kettering Cancer Center, will be published in the March 22 issue of the New England Journal of Medicine.
"Our study shows that genetic profiling makes it possible to more precisely categorize which patients are most likely to have their leukemia return after treatment," says the study's lead author Ross Levine, MD, a member of Memorial Sloan-Kettering's Human Oncology Pathogenesis Program. "We also want to use existing therapies more intelligently. It helps a great deal to know which subset of patients will actually benefit from intensive therapies, such as a higher dose of chemotherapy or a bone marrow transplant," adds Dr. Levine, who is also a medical oncologist on the Leukemia Service at Memorial Sloan-Kettering.
At present, clinicians rely on only a handful of known genetic biomarkers (early markers of disease) to predict outcome in leukemia patients, and these biomarkers provide useful information for only a subset of patients. For most people diagnosed with AML, it is difficult to predict the chance for a cure.
The method used in the study incorporates information from an array of genes and allows nearly two-thirds of patients to be categorized into clearly defined prognostic groups. "Our goal was not to ask whether a certain gene or two raised or lowered risk, but to determine whether a combination of characteristics from a set of genes made it possible to precisely stratify patients according to risk," Dr. Levine says.
The researchers analyzed blood or bone marrow samples from 502 patients with AML who were participating in a clinical trial. Such samples are routinely taken for research purposes during trials with patient consent. The trial, led by Martin S. Tallman, MD, Chief of Memorial Sloan-Kettering's Leukemia Service, explored whether increasing the standard dose of chemotherapy in AML patients under age 60 would improve survival.
The team that performed the genetic analysis, which included investigators from Memorial Sloan-Kettering, Weill Cornell Medical College, and other institutions, analyzed the samples for abnormalities, or mutations, within 18 genes known to have alterations in people with AML. The researchers noted the relationship between the mutations present in each patient and how that patient ultimately fared with the disease receiving either the standard or increased chemotherapy dose.
"Our findings have important clinical implications for patients with AML, demonstrating that genetic profiling can improve current prognostic models and help guide therapeutic decisions so patients have an optimal result," says Dr. Tallman, who is a co-author of the new study. "Moving forward, the challenge will be to provide this genetic information in a timely and affordable way to influence treatment decisions prospectively," he adds.
The analysis allowed the researchers to determine specific risk levels for a variety of gene-mutation combinations. They also were able to establish that the higher chemotherapy dose used in the trial benefited only some of the patients. The investigators took into account variables such as patient age and gender and validated the results in a separate group of patients to ensure that the profiling approach will be generally applicable beyond the current trial.
Dr. Levine and his Memorial Sloan-Kettering colleagues are working to translate the results from the study into clinical use. "We've already developed genetic tests, which can be used to test for this set of mutations in patients, and we're in the process of making sure they work well in practice," he says. "We have preliminary evidence that they perform well, and we're hoping to have a pilot study soon as a step toward getting it into the clinic. We want to show this approach can be used not just at Memorial Sloan-Kettering but throughout the leukemia community."
The American Cancer Society estimates that 13,780 people in the United States will be diagnosed with AML in 2012 and that more than 10,000 people will die from the disease.
INFORMATION:
Researchers from Weill Cornell Medical College, Moffitt Cancer Center, Dana-Farber Cancer Institute, Montefiore Medical Center, Columbia University Medical Center, Columbia University, Stanford Hospital and Clinics, Indiana University School of Medicine, Abbott Northwestern Hospital, Mayo Clinic College of Medicine, Case Western Reserve University School of Medicine, Israel Institute of Technology, and University of Pennsylvania School of Medicine contributed to the study.
The work was supported by grants from the National Cancer Institute, Gabrielle's Angel Fund, the Starr Cancer Consortium, and the Peter Solomon Fund at Memorial Sloan-Kettering.
Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose, and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide. For more information, go to www.mskcc.org.
END
Silver nanoparticles cause more damage to testicular cells than titanium dioxide nanoparticles, according to a recent study by the Norwegian Institute of Public Health. However, the use of both types may affect testicular cells with possible consequences for fertility.
Commonly used
Nanotechnology is increasingly used in consumer products, medicines and building products. The potential risks of using engineered nanoparticles need to be monitored so that the industry can develop products that are safe for humans and nature.
Previous research has shown that nanoparticles ...
Atlanta pest control company North Fulton Pest Solutions encourages homeowners as well as business owners to schedule termite inspections and treatments for the spring. Spring is the breeding season (or "swarm season") for termites, so a well-scheduled Atlanta termite treatment can help stop an infestation before it starts or becomes worse.
"Spring is a prime time for termite treatments in Atlanta," says Blake Edwards, Director of Business Development for North Fulton Pest Solutions. "Termites swarm and breed in spring, creating new colonies ...
Female sex workers in low- and middle-income countries are nearly 14 times more likely to be infected by HIV compared to the rest of country's population, according to an analysis by researchers at the Johns Hopkins Bloomberg School of Public Health. The findings suggest an urgent need to scale up access to quality HIV prevention programs in these countries. The study was published online in The Lancet Infectious Diseases.
"Although female sex workers have long been understood to be a key affected population, the scope and breadth of their disproportionate risk for HIV ...
LEXINGTON, Ky. (March 14, 2012) — A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age.
Tumor cells can exploit a cellular program that promotes cell migration and reduces adhesion between cells to spread to distant sites in the body. This cellular program, known as the epithelial-mesenchymal transition, requires large-scale ...
DETROIT – A combined therapy of common acne medications was shown to be a potent regimen for treating patients with severe facial acne, according to two published studies involving Henry Ford Hospital.
The companion studies found that a therapy of the topical Epiduo Gel containing adapalene and benzoyl peroxide and the antibiotic doxycycline proved more effective at reducing acne lesions compared to other treatment regimens.
Of the 459 patients involved in the study, 76 percent of those who received the regimen of
Epiduo Gel and doxycycline as initial therapy for ...
Atlanta moving company A.C. White Relocations reminds homeowners to reserve a slot with Atlanta movers early for the busy summer moving season. If you are planning to move this summer, you need to start contacting Atlanta moving companies as soon as possible.
Truck drivers in the Atlanta moving industry have been in short supply over the past few years, so movers in Atlanta like A.C. White Relocations tend to book up quickly during the busy summer months. Often if Atlanta homeowners wait until even a couple of months in advance, they may find the majority or even all ...
DURHAM, N.H. – A parking lot at the edge of the University of New Hampshire campus has contributed important research to an emerging concern for the environment and human health.
The research, detailed in a recent feature article in the journal Environmental Science & Technology, has found that one type of pavement sealcoat, common on driveways and parking lots throughout the nation, has significant health and ecosystem implications. Alison Watts, research assistant professor of civil engineering at UNH, is a co-author of the article "Coal-Tar-Based Pavement Sealcoat ...
Using radio and infrared telescopes, astronomers have obtained a first tantalizing look at a crucial early stage in star formation. The new observations promise to help scientists understand the early stages of a sequence of events through which a giant cloud of gas and dust collapses into dense cores that, in turn, form new stars.
The scientists studied a giant cloud about 770 light-years from Earth in the constellation Perseus. They used the European Space Agency's Herschel Space Observatory and the National Science Foundation's Green Bank Telescope (GBT) to make detailed ...
CHAMPAIGN, Ill. — Those motivated to actively change bad habits may be setting themselves up for failure, a new study suggests.
The study, described in an article in the journal Motivation and Emotion, found that people primed with words suggesting action were more likely than others to make impulsive decisions that undermined their long-term goals. In contrast, those primed to "rest," to "stop" or to be inactive found it easier to avoid impulsive decisions.
"Popular views of self-control maintain that individuals should 'exert' willpower, 'fight' temptations, 'overcome' ...
Copenhagen, Denmark – Important progress has been achieved towards including genomic-level information in the data made freely available through GBIF.
Successful alignment of informatics standards for recording species occurrences and gene-sequence descriptions has opened up new possibilities for integrating the different types of data.
The mapping of three standards was completed at a GBIF-led workshop in Oxford, United Kingdom bringing together experts from Europe, the United States, China and Japan.
A testing programme will shortly begin to bring data from several ...
